Twist Bioscience (TWST) Accumulated Expenses (2018 - 2026)

Twist Bioscience (TWST) has 9 years of Accumulated Expenses data on file, last reported at $27.0 million in Q1 2026.

• Accumulated Expenses for Q1 2026 came in at $27.0 million, up 8.36% year-over-year; the trailing twelve-month figure through Mar 2026 was $27.0 million (up 8.36% YoY), and the FY2025 annual result was $31.3 million, up 107.15% from the prior year.
• Accumulated Expenses climbed to $27.0 million in Q1 2026 per TWST's latest filing, from $18.8 million in the prior quarter.
• Over five years, Accumulated Expenses peaked at $31.7 million in Q2 2024 and troughed at $10.3 million in Q2 2023.
• A 5-year average of $22.1 million and a median of $24.3 million in 2023 frame the typical range for Accumulated Expenses.
• The sharpest annual moves came in 2022 and 2023: Accumulated Expenses soared 469.1% in 2022, then sank 62.77% in 2023.
• A 5-year view of Accumulated Expenses shows it stood at $23.3 million in 2022, then sank by 40.03% to $14.0 million in 2023, then soared by 44.2% to $20.1 million in 2024, then declined by 6.43% to $18.8 million in 2025, then jumped by 43.37% to $27.0 million in 2026.
• Business Quant data shows TWST's Accumulated Expenses at $27.0 million in Q1 2026, $18.8 million in Q4 2025, and $31.3 million in Q3 2025.